Vitamin D control of calorie allocation to muscle
维生素 D 控制肌肉的热量分配
基本信息
- 批准号:10567569
- 负责人:
- 金额:$ 54.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AreaBindingBinding SitesBiological AssayBody Weight decreasedCalcifediolCalcitriolCalciumCaloric RestrictionCaloriesCell Culture TechniquesDNA BindingDataDedicationsDevelopmentDiabetes MellitusDiseaseDoseElementsEnzymesExerciseFatty acid glycerol estersGene ExpressionGenerationsGenesGenetic TranscriptionGenetically Engineered MouseGoalsHand StrengthHealthHeart DiseasesHydroxylationIn VitroIncidenceKnock-outKnockout MiceLongevityMalignant NeoplasmsMapsMeasuresMediatingMetabolismMitochondriaMixed Function OxygenasesModelingMusMuscleMuscle MitochondriaMuscle functionObese MiceObesityOutputOxidative PhosphorylationPathway interactionsPennsylvaniaQualifyingQuality of lifeReceptor SignalingResearchResearch PersonnelResistanceRiskRoleRunningSerumSignal PathwaySignal TransductionTestingTherapeuticThinnessTimeTranscriptional RegulationUniversitiesVitamin DVitamin D Response ElementVitamin D3 ReceptorWorkcareerdaily functioningdiabetes riskdietarygenome-widegenome-wide analysisimprovedin vivomouse modelmuscle formmuscle physiologynew therapeutic targetnovelnovel therapeutic interventionobesity riskobesity treatmentpreventprofessorreceptor bindingresponseside effecttargeted treatmenttenure tracktranscriptometranscriptome sequencingtreadmill
项目摘要
PROJECT SUMMARY/ABSTRACT
Obesity causes the greatest proportional risk for diabetes, heart disease, and cancer and is resistant to current
treatments despite being a focus of intense research. Obesity occurs because the body stores surplus calories
as fat, which in turn drives the health risks associated with obesity6-10. The current therapeutic approaches to
obesity focus on weight loss, via caloric restriction and/or exercise, which are not effective. An alternate strategy
would be to redirect surplus calories to build muscle instead of storage as fat. This approach would mitigate the
health risks of obesity and also improve daily functioning, quality of life, and longevity. Our intriguing preliminary
data reveal that high-dose dietary vitamin D decreases the proportion of excess calories stored as fat, instead
allocating these calories to muscle. Understanding the mechanisms underlying this finding will drive the
development of novel therapeutic approaches desperately needed to prevent and treat obesity. Further, our
preliminary results suggest that this calorie allocation to muscle occurs via 25D mediated vitamin D receptor
(VDR) transcriptional regulation at non-canonical VDR binding sites.
Our long term goal is to define the roles of vitamin D in calorie allocation in order to identify novel therapeutic
targets in obesity. The specific objectives of this project are 1) to determine which dietary vitamin D metabolite,
25D or 1,25D, signals to allocate calories to muscle, and 2) to identify the mechanisms in muscle whereby vitamin
D signaling leads to changes in gene expression underlying calorie allocation. Using mouse models, we have
demonstrated that high-dose dietary vitamin D increases muscle mass, cross sectional area, strength/area, and
muscle mitochondrial capacity in both lean and obese mice. Our central hypothesis is that high-dose vitamin
D calorie allocation is mediated by 25D acting via the VDR to alter transcription through non-canonical binding
sites. Our approach uses validated genetically engineered mouse models of vitamin D imbalance, and connects
signaling to transcriptional changes by genome-wide analysis of VDR binding.
In sum, this proposal describes a five-year research plan to understand the mechanisms underlying non-
calciometabolic actions of vitamin D to preferentially allocate calories to muscle instead of fat with the long-term
goal of developing novel rational therapies for obesity. The primary investigator is an Assistant Professor on the
tenure track at the University of Pennsylvania. He is an early career researcher dedicated to asking translational
questions to better understand non-calciometabolic actions of vitamin D. He has assembled a uniquely qualified
and complementary collaborative team to tackle the objectives of this application. Successful completion of this
work will define the role of 25D in mediating vitamin D muscle calorie allocation and will identify relevant signaling
pathways that could be targeted therapeutically to preferentially allocate surplus calories to muscle instead of
fat, thereby decreasing both unwanted effects and incidence of obesity.
项目总结/摘要
肥胖导致糖尿病、心脏病和癌症的最大比例风险,
治疗,尽管它是一个密集的研究的焦点。肥胖的发生是因为身体储存了多余的卡路里
作为脂肪,这反过来又推动了与肥胖相关的健康风险6 -10。目前的治疗方法,
肥胖症集中于通过热量限制和/或锻炼来减轻体重,这是无效的。另一种策略
将多余的卡路里转化为肌肉,而不是储存为脂肪。这种方法将减轻
肥胖的健康风险,并改善日常功能,生活质量和长寿。我们有趣的初步调查
数据显示,高剂量的膳食维生素D减少了多余的卡路里以脂肪形式储存的比例,
将这些热量分配给肌肉。了解这一发现背后的机制将推动
开发预防和治疗肥胖症迫切需要的新治疗方法。此外,我们的
初步结果表明,这种热量分配给肌肉是通过25 D介导的维生素D受体发生的
(VDR)在非典型VDR结合位点的转录调控。
我们的长期目标是确定维生素D在卡路里分配中的作用,以确定新的治疗方法。
肥胖的目标。该项目的具体目标是:1)确定哪些膳食维生素D代谢物,
25 D或1,25 D,信号分配卡路里的肌肉,和2)确定机制,在肌肉中,维生素
D信号导致基因表达的变化,这些变化是热量分配的基础。使用小鼠模型,我们有
证明高剂量的膳食维生素D增加肌肉质量,横截面积,强度/面积,
肌肉线粒体的能力。我们的核心假设是高剂量维生素
25 D通过VDR作用,通过非典型结合改变转录,从而介导D卡路里分配
网站.我们的方法使用了经过验证的维生素D不平衡的基因工程小鼠模型,
通过VDR结合的全基因组分析,
总之,该提案描述了一个五年研究计划,以了解非
维生素D的钙代谢作用,优先分配热量给肌肉,而不是脂肪,长期
目的是开发新的合理的肥胖疗法。主要研究者是一名助理教授,
宾夕法尼亚大学的终身教职他是一个早期的职业研究人员,致力于问翻译
问题,以更好地了解维生素D的非钙代谢作用。他召集了一个独一无二的
和互补的协作团队来解决这个应用程序的目标。成功完成本
这项工作将确定25 D在介导维生素D肌肉卡路里分配中的作用,并将确定相关的信号传导
这些途径可以在治疗上有针对性地优先将多余的卡路里分配给肌肉,
脂肪,从而减少不必要的影响和肥胖的发生率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey David Roizen其他文献
Jeffrey David Roizen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey David Roizen', 18)}}的其他基金
Regulation of serum vitamin D (calcidiol - 25(OH)D) by CYP2R1
CYP2R1 对血清维生素 D(骨化二醇 - 25(OH)D)的调节
- 批准号:
9087394 - 财政年份:2016
- 资助金额:
$ 54.41万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 54.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 54.41万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 54.41万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 54.41万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 54.41万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 54.41万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 54.41万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 54.41万 - 项目类别:
Standard Grant